Sefiert et al. (7) revealed that manifestations of bones and joints found in patients with homozygous mutations in the HPGD, usually appear earlier than those in the SLCO2A1, suggesting the clinical heterogeneity between the two subtypes of PHO. Here, SLCO2A1 is linked to primary hypertrophic osteoarthropathy.